Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors

Kaori Asai, Katsumasa Nakamura, Yoshiyuki Shioyama, Tomonari Sasaki, Yoshio Matsuo, Ohga Saiji, Tadamasa Yoshitake, Kotaro Terashima, Makoto Shinoto, Keiji Matsumoto, Hidenari Hirata, Hiroshi Honda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Backgound: We retrospectively investigated the clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy (SBRT) for lung tumors. Methods: Between April 2003 and July 2012, 473 patients with lung tumors were treated with SBRT. We identified 12 patients (2.5 %) with pneumothorax caused by SBRT, and evaluated the clinical features of pneumothorax. Results: All of the tumors were primary lung cancers. The severity of radiation pneumonitis was grade 1 in 10 patients and grade 2 in two patients. Nine patients had emphysema. The planning target volume and pleura overlapped in 11 patients, and the tumors were attached to the pleura in 7 patients. Rib fractures were observed in three patients before or at the same time as the diagnosis of pneumothorax. The median time to onset of pneumothorax after SBRT was 18.5 months (4–84 months). The severity of pneumothorax was grade 1 in 11 patients and grade 3 in one patient. Conclusion: Although pneumothorax was a relatively rare late adverse effect after SBRT, some patients demonstrated pneumothorax after SBRT for peripheral lung tumors. Although most pneumothorax was generally tolerable and self-limiting, careful follow-up is needed.

Original languageEnglish
Pages (from-to)1117-1121
Number of pages5
JournalInternational Journal of Clinical Oncology
Volume20
Issue number6
DOIs
Publication statusPublished - Dec 1 2015

Fingerprint

Radiosurgery
Pneumothorax
Lung
Neoplasms
Pleura
Radiation Pneumonitis
Rib Fractures
Emphysema
Lung Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hematology
  • Oncology

Cite this

Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors. / Asai, Kaori; Nakamura, Katsumasa; Shioyama, Yoshiyuki; Sasaki, Tomonari; Matsuo, Yoshio; Saiji, Ohga; Yoshitake, Tadamasa; Terashima, Kotaro; Shinoto, Makoto; Matsumoto, Keiji; Hirata, Hidenari; Honda, Hiroshi.

In: International Journal of Clinical Oncology, Vol. 20, No. 6, 01.12.2015, p. 1117-1121.

Research output: Contribution to journalArticle

Asai, Kaori ; Nakamura, Katsumasa ; Shioyama, Yoshiyuki ; Sasaki, Tomonari ; Matsuo, Yoshio ; Saiji, Ohga ; Yoshitake, Tadamasa ; Terashima, Kotaro ; Shinoto, Makoto ; Matsumoto, Keiji ; Hirata, Hidenari ; Honda, Hiroshi. / Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors. In: International Journal of Clinical Oncology. 2015 ; Vol. 20, No. 6. pp. 1117-1121.
@article{9518b2805bc44caabd0082cc3216a68d,
title = "Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors",
abstract = "Backgound: We retrospectively investigated the clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy (SBRT) for lung tumors. Methods: Between April 2003 and July 2012, 473 patients with lung tumors were treated with SBRT. We identified 12 patients (2.5 {\%}) with pneumothorax caused by SBRT, and evaluated the clinical features of pneumothorax. Results: All of the tumors were primary lung cancers. The severity of radiation pneumonitis was grade 1 in 10 patients and grade 2 in two patients. Nine patients had emphysema. The planning target volume and pleura overlapped in 11 patients, and the tumors were attached to the pleura in 7 patients. Rib fractures were observed in three patients before or at the same time as the diagnosis of pneumothorax. The median time to onset of pneumothorax after SBRT was 18.5 months (4–84 months). The severity of pneumothorax was grade 1 in 11 patients and grade 3 in one patient. Conclusion: Although pneumothorax was a relatively rare late adverse effect after SBRT, some patients demonstrated pneumothorax after SBRT for peripheral lung tumors. Although most pneumothorax was generally tolerable and self-limiting, careful follow-up is needed.",
author = "Kaori Asai and Katsumasa Nakamura and Yoshiyuki Shioyama and Tomonari Sasaki and Yoshio Matsuo and Ohga Saiji and Tadamasa Yoshitake and Kotaro Terashima and Makoto Shinoto and Keiji Matsumoto and Hidenari Hirata and Hiroshi Honda",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s10147-015-0833-4",
language = "English",
volume = "20",
pages = "1117--1121",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors

AU - Asai, Kaori

AU - Nakamura, Katsumasa

AU - Shioyama, Yoshiyuki

AU - Sasaki, Tomonari

AU - Matsuo, Yoshio

AU - Saiji, Ohga

AU - Yoshitake, Tadamasa

AU - Terashima, Kotaro

AU - Shinoto, Makoto

AU - Matsumoto, Keiji

AU - Hirata, Hidenari

AU - Honda, Hiroshi

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Backgound: We retrospectively investigated the clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy (SBRT) for lung tumors. Methods: Between April 2003 and July 2012, 473 patients with lung tumors were treated with SBRT. We identified 12 patients (2.5 %) with pneumothorax caused by SBRT, and evaluated the clinical features of pneumothorax. Results: All of the tumors were primary lung cancers. The severity of radiation pneumonitis was grade 1 in 10 patients and grade 2 in two patients. Nine patients had emphysema. The planning target volume and pleura overlapped in 11 patients, and the tumors were attached to the pleura in 7 patients. Rib fractures were observed in three patients before or at the same time as the diagnosis of pneumothorax. The median time to onset of pneumothorax after SBRT was 18.5 months (4–84 months). The severity of pneumothorax was grade 1 in 11 patients and grade 3 in one patient. Conclusion: Although pneumothorax was a relatively rare late adverse effect after SBRT, some patients demonstrated pneumothorax after SBRT for peripheral lung tumors. Although most pneumothorax was generally tolerable and self-limiting, careful follow-up is needed.

AB - Backgound: We retrospectively investigated the clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy (SBRT) for lung tumors. Methods: Between April 2003 and July 2012, 473 patients with lung tumors were treated with SBRT. We identified 12 patients (2.5 %) with pneumothorax caused by SBRT, and evaluated the clinical features of pneumothorax. Results: All of the tumors were primary lung cancers. The severity of radiation pneumonitis was grade 1 in 10 patients and grade 2 in two patients. Nine patients had emphysema. The planning target volume and pleura overlapped in 11 patients, and the tumors were attached to the pleura in 7 patients. Rib fractures were observed in three patients before or at the same time as the diagnosis of pneumothorax. The median time to onset of pneumothorax after SBRT was 18.5 months (4–84 months). The severity of pneumothorax was grade 1 in 11 patients and grade 3 in one patient. Conclusion: Although pneumothorax was a relatively rare late adverse effect after SBRT, some patients demonstrated pneumothorax after SBRT for peripheral lung tumors. Although most pneumothorax was generally tolerable and self-limiting, careful follow-up is needed.

UR - http://www.scopus.com/inward/record.url?scp=84948718987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948718987&partnerID=8YFLogxK

U2 - 10.1007/s10147-015-0833-4

DO - 10.1007/s10147-015-0833-4

M3 - Article

C2 - 25917776

AN - SCOPUS:84948718987

VL - 20

SP - 1117

EP - 1121

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 6

ER -